Skip to main content

Receptos Inc (NASDAQ:RCPT) Investor Filed Lawsuit Over Alleged Wrongdoing In Acquisition By Celgene Corporation

  • If you purchased shares of Receptos Inc (NASDAQ:RCPT) and currently hold any of those NASDAQ:RCPT shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

July 24, 2015 (Shareholders Foundation) - An investor who currently holds shares of Receptos Inc (NASDAQ:RCPT), filed a lawsuit in effort to halt the proposed takeover of Receptos by Celgene Corporation for $232.00 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:RCPT stockholders by agreeing to sell Receptos Inc too cheaply via an u...



You must register (for free) or login to view the entire case.